Skip to main content

CORRECTION article

Front. Pharmacol. , 03 December 2018

Sec. Ethnopharmacology

Volume 9 - 2018 | https://doi.org/10.3389/fphar.2018.01420

This article is part of the Research Topic Assessing the Pharmacological Effects and Therapeutic Efficacy of Traditional Chinese Medicine in Neurological Disease Models View all 16 articles

Corrigendum: Modified Xiaoyaosan (MXYS) Exerts Anti-depressive Effects by Rectifying the Brain Blood Oxygen Level-Dependent FMRI Signals and Improving Hippocampal Neurogenesis in Mice

\r\nLei Gao&#x;Lei Gao1†Peng Huang&#x;Peng Huang1†Zhaoyang Dong&#x;Zhaoyang Dong2†Tingting GaoTingting Gao1Shaohui HuangShaohui Huang1Chuying ZhouChuying Zhou1Yuling LaiYuling Lai1Guanghui DengGuanghui Deng1Bin Liu*Bin Liu3*Ge Wen*Ge Wen4*Zhiping Lv*Zhiping Lv1*
  • 1School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China
  • 2School of Nursing, Guangzhou University of Chinese Medicine, Guangzhou, China
  • 3Zhujiang Hospital, Southern Medical University, Guangzhou, China
  • 4Nanfang Hospital, Southern Medical University, Guangzhou, China

This article is a correction to:

  1. Modified Xiaoyaosan (MXYS) Exerts Anti-depressive Effects by Rectifying the Brain Blood Oxygen Level-Dependent fMRI Signals and Improving Hippocampal Neurogenesis in Mice

    1. Read original article

A Corrigendum on
Modified Xiaoyaosan (MXYS) Exerts Anti-depressive Effects by Rectifying the Brain Blood Oxygen Level-Dependent FMRI Signals and Improving Hippocampal Neurogenesis in Mice

by Gao L, Huang P, Dong Z, Gao T, Huang S, Zhou C, et al. (2018) Front. Pharmacol. 9:1098. doi: 10.3389/fphar.2018.01098

There is an error in the Funding statement. The correct number for the National Natural Science Foundation of China is 81230085. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Keywords: depression, FMRI, traditional Chinese medicine, hippocampus, blood oxygen level-dependent

Citation: Gao L, Huang P, Dong Z, Gao T, Huang S, Zhou C, Lai Y, Deng G, Liu B, Wen G and Lv Z (2018) Corrigendum: Modified Xiaoyaosan (MXYS) Exerts Anti-depressive Effects by Rectifying the Brain Blood Oxygen Level-Dependent FMRI Signals and Improving Hippocampal Neurogenesis in Mice. Front. Pharmacol. 9:1420. doi: 10.3389/fphar.2018.01420

Received: 16 November 2018; Accepted: 19 November 2018;
Published: 03 December 2018.

Approved by:

Frontiers in Pharmacology Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2018 Gao, Huang, Dong, Gao, Huang, Zhou, Lai, Deng, Liu, Wen and Lv. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Bin Liu, nysylb@163.com
Ge Wen, 1113470826@qq.com
Zhiping Lv, lzp48241@126.com

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

Man ultramarathon runner in the mountains he trains at sunset

95% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more